Mast cells and immunoregulation/immunomodulation

Advances in Experimental Medicine and Biology

Volumn 716, Issue , 2011, Pages 186-211

  Tsai, Mindy ^a   Grimbaldeston, Michele ^b   Galli, Stephen J ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYPEPTIDASE A; CELL SURFACE RECEPTOR; CRE RECOMBINASE; FC EPSILON RECEPTOR I; FC RECEPTOR; PATTERN RECOGNITION RECEPTOR; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANTIBODY RESPONSE; ARTICLE; ASTHMA; B LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL FUNCTION; CELL INTERACTION; CYTOKINE RELEASE; GENE DELETION; HOST RESISTANCE; HUMAN; IMMUNOGLOBULIN PRODUCTION; IMMUNOMODULATION; IMMUNOPATHOGENESIS; IMMUNOREGULATION; INFECTION RESISTANCE; LYMPHOCYTE FUNCTION; MAST CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR UPREGULATION; TRANSGENIC MOUSE; ULTRAVIOLET B RADIATION; ANIMAL; IMMUNOLOGY; MOUSE; REVIEW;

ANIMALS; HUMANS; IMMUNOMODULATION; MAST CELLS; MICE;

EID: 79960912132     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-9533-9_11     Document Type: Article

References (184)

1. Kitamura Y. Heterogeneity of mast cells and phenotypic change between subpopulations. Annu Rev Immunol 1989; 7:59-76. (Pubitemid 19138007)
2. Metcalfe DD, Baram D, Mekori YA. Mast cells. Physiol Rev 1997; 77:1033-79. (Pubitemid 27459579)
3. Kawakami T, Galli SJ. Regulation of mast-cell and basophil function and survival by IgE. Nat Rev Immunol 2002; 2:773-86. (Pubitemid 37328717)
4. Ryan JJ, Kashyap M, Bailey D et al. Mast cell homeostasis: a fundamental aspect of allergic disease. Crit Rev Immunol 2007; 27:15-32. (Pubitemid 46659045)
5. Marshall JS. Mast-cell responses to pathogens. Nat Rev Immunol 2004; 4:787-99. (Pubitemid 39336295)
6. Galli SJ, Kalesnikoff J, Grimbaldeston MA et al. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu Rev Immunol 2005; 23:749-86. (Pubitemid 40563184)
7. Galli SJ, Nakae S, Tsai M. Mast cells in the development of adaptive immune responses. Nat Immunol 2005; 6:135-42. (Pubitemid 40268194)
8. Abraham SN, St John AL. Mast cell-orchestrated immunity to pathogens. Nat Rev Immunol 2010; 10:440-52.
9. Moon TC, St Laurent CD, Morris KE et al. Advances in mast cell biology: new understanding ofheterogeneity and function. Mucosal Immunol 2010; 3:111-28.
10. Grimbaldeston MA, Metz M, Yu M et al. Effector and potential immunoregulatory roles of mast cells in IgE-associated acquired immune responses. Curr Opin Immunol 2006; 18:751-60. (Pubitemid 44642318)
11. Dawicki W, Marshall JS. New and emerging roles for mast cells in host defence. Curr Opin Immunol 2007; 19:31-8. (Pubitemid 46073696)
12. Sayed BA, Brown MA. Mast cells as modulators of T-cell responses. Immunol Rev 2007; 217:53-64. (Pubitemid 46718157)
13. Galli SJ, Grimbaldeston M, Tsai M. Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nat Rev Immunol 2008; 8:478-86. (Pubitemid 351733419)
14. Mekori YA, Metcalfe DD. Mast cells in innate immunity. Immunol Rev 2000; 173:131-40. (Pubitemid 30095217)
15. Malaviya R, Abraham SN. Mast cell modulation of immune responses to bacteria. Immunol Rev 2001; 179:16-24. (Pubitemid 32171270)
16. Sayed BA, Christy A, Quirion MR et al. The master switch: the role of mast cells in autoimmunity and tolerance. Annu Rev Immunol 2008; 26:705-39. (Pubitemid 351600390)
17. Maurer M et al. Mast cells promote homeostasis by limiting endothelin-1-induced toxicity. Nature 2004; 432:512-6. (Pubitemid 39576533)
18. Metz M, Piliponsky AM, Chen CC et al. Mast cells can enhance resistance to snake and honeybee venoms. Science 2006; 313:526-30. (Pubitemid 44148458)
19. Piliponsky AM, Chen CC, Nishimura T et al. Neurotensin increases mortality and mast cells reduce neurotensin levels in a mouse model of sepsis. Nat Med 2008; 14:392-8. (Pubitemid 351499391)
20. Schneider LA, Schlenner SM, Feyerabend TB et al. Molecular mechanism of mast cell mediated innate defense against endothelin and snake venom sarafotoxin. J Exp Med 2007; 204:2629-39. (Pubitemid 350044788)
21. Brown JM, Wilson TM, Metcalfe DD. The mast cell and allergic diseases: role in pathogenesis and implications for therapy. Clin Exp Allergy 2008; 38:4-18. (Pubitemid 350233400)
22. Frandji P, Oskeritzian C, Cacaraci F et al. Antigen-dependent stimulation by bone marrow-derived mast cells of MHC class II-restricted T-cell hybridoma. J Immunol 1993; 151:6318-28. (Pubitemid 23340378)
23. Hart PH, Grimbaldeston MA, Swift GJ et al. Dermal mast cells determine susceptibility to ultraviolet B-induced systemic suppression ofcontact hypersensitivity responses in mice. J Exp Med1998; 187:2045-53. (Pubitemid 28285574)
24. Grimbaldeston MA, Nakae S, Kalesnikoff J et al. Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nat Immunol 2007; 8:1095-104. (Pubitemid 47423757)
25. Mills KH. Regulatory T-cells: friend or foe in immunity to infection? Nat Rev Immunol 2004; 4:841-55. (Pubitemid 39490760)
26. Grimbaldeston MA, Chen CC, Piliponsky AM et al. Mast cell-deficient W-sash c-kit mutant KitW-sWW-si mice as a model for investigating mast cell biology in vivo. Am J Pathol 2005; 167:835-48. (Pubitemid 41216366)
27. Wolters PJ, Mallen-St Clair J, Lewis CC et al. Tissue-selective mast cell reconstitution and differential lung gene expression in mast cell-deficient KitW-shW-sh sash mice. Clin Exp Allergy 2005; 35:82-8. (Pubitemid 40188275)
28. Nigrovic PA, Gray DH, Jones T et al. Genetic inversion in mast cell-deficient Wsh mice interrupts corin and manifests as hematopoietic and cardiac aberrancy. Am J Pathol 2008; 173:1693-701.
29. Zhou JS, Xing W, Friend DS et al. Mast cell deficiency in KitW-sh mice does not impair antibody-mediated arthritis. J Exp Med 2007; 204:2797-802. (Pubitemid 350179550)
30. Piliponsky AM, Chen CC, Grimbaldeston MA et al. Mast cell-derived TNF can exacerbate mortality during severe bacterial infections in C57BL/6-KitW-sh/W-sh mice. Am J Pathol 2010; 176:926-38.
31. Feyerabend TB, Hausser H, Tietz A et al. Loss ofhistochemical identity in mast cells lacking carboxypeptidase A. Mol Cell Biol 2005; 25:6199-210. (Pubitemid 40946568)
32. Knight PA, Wright SH, Lawrence CE et al. Delayed expulsion of the nematode Trichinella spiralis in mice lacking the mucosal mast cell-specific granule chymase, mouse mast cell protease-1. J Exp Med 2000; 192:1849-56. (Pubitemid 32049777)
33. Pejler G, Abrink M, Ringvall M et al. Mast cell proteases. Adv Immunol 2007; 95:167-255. (Pubitemid 47380506)
34. Thakurdas SM, Melicoff E, Sansores-Garcia L et al. The mast cell-restricted tryptase mMCP-6 has a critical immunoprotective role in bacterial infections. J Biol Chem 2007; 282:20809-15. (Pubitemid 47099914)
35. Musch W, Wege AK, Mannel DN et al. Generation and characterization of alpha-chymase-Cre transgenic mice. Genesis 2008; 46:163-6. (Pubitemid 351554745)
36. Scholten J, Hartmann K, Gerbaulet A et al. Mast cell-specific Cre/loxP-mediated recombination in vivo. Transgenic Res 2008; 17:307-15.
37. Feyerabend TB, Terszowski G, Tietz A et al. Deletion of Notch1 converts pro-T cells to dendritic cells and promotes thymic B-cells by cell-extrinsic and cell-intrinsic mechanisms. Immunity 2009; 30:67-79.
38. Newlands GF, Miller HR, MacKellar A et al. Stem cell factor contributes to intestinal mucosal mast cell hyperplasia in rats infected with Nippostrongylus brasiliensis or Trichinella spiralis, but anti-stem cell factor treatment decreases parasite egg production during N. brasiliensis infection. Blood1995; 86:1968-76.
39. Brandt EB, Strait RT, Hershko D et al. Mast cells are required for experimental oral allergen-induced diarrhea. J Clin Invest 2003; 112:1666-77. (Pubitemid 38063724)
40. Gekara NO, Weiss S. Mast cells initiate early anti-Listeria host defences. Cell Microbiol 2008; 10:225-36. (Pubitemid 350239068)
41. Dietrich N, Rohde M, Geffers R et al. Mast cells elicit proinflammatory but not type I interferon responses upon activation of TLRs by bacteria. Proc Natl Acad Sci USA 2010; 107:8748-53.
42. Soucek L, Lawlor ER, Soto D et al. Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors. Nat Med 2007; 13:1211-8.
43. Sun J, Sukhova GK, Yang M et al. Mast cells modulate the pathogenesis of elastase-induced abdominal aortic aneurysms in mice. J Clin Invest 2007; 117:3359-68. (Pubitemid 350096992)
44. Arumugam T, Ramachandran V, Logsdon CD. Effect of cromolyn on S100P interactions with RAGE and pancreatic cancer growth and invasion in mouse models. J Natl Cancer Inst 2006; 98:1806-18. (Pubitemid 46017932)
45. Norris AA. Pharmacology of sodium cromoglycate. Clin Exp Allergy 26 Suppl 1996; 4:5-7. (Pubitemid 26201804)
46. Blank U, Rivera J. The ins and outs ofIgE-dependent mast-cell exocytosis. Trends Immunol 2004; 25:266-73. (Pubitemid 38501673)
47. Gilfillan AM, Tkaczyk C. Integrated signalling pathways for mast-cell activation. Nat Rev Immunol 2006: 6:218-30. (Pubitemid 43290991)
48. Metcalfe DD, Peavy RD, Gilfillan AM. Mechanisms of mast cell signaling in anaphylaxis. J Allergy Clin Immunol 2009; 124:639-46; quiz 647-8.
49. RiveraJ,GilfillanAM. Molecular regulation ofmastcell activation. JAllergy ClinImmunol2006:117:1214-25.
50. Kalesnikoff J, Galli SJ. New developments in mast cell biology. Nat Immunol 2008; 9:1215-23.
51. Gonzalez-Espinosa C, Odom S, Olivera A et al. Preferential signaling and induction of allergy-promoting lymphokines upon weak stimulation of the high affinity IgE receptor on mast cells. J Exp Med 2003: 197:1453-65. (Pubitemid 36682544)
52. Chong HJ, Andrew Bouton L, Bailey DP et al. IL-4 selectively enhances FcgammaRIII expression and signaling on mouse mast cells. Cell Immunol 2003; 224:65-73.
53. Andreu P, Johansson M, Affara NI et al. FcRgamma activation regulates inflammation-associated squamous carcinogenesis. Cancer Cell 2010; 17:121-34.
54. Okayama Y, Kirshenbaum AS, Metcalfe DD. Expression of a functional high-affinity IgG receptor, Fc gamma RI, on human mast cells: up-regulation by IFN-gamma. J Immunol 2000; 164:4332-9. (Pubitemid 30215096)
55. Metz M, Grimbaldeston MA, Nakae S et al. Mast cells in the promotion and limitation of chronic inflammation. Immunol Rev 2007; 217:304-28. (Pubitemid 46718153)
56. Heib V, Becker M, Warger T et al. Mast cells are crucial for early inflammation, migration of Langerhans cells and CTL responses following topical application of TLR7 ligand in mice. Blood 2007; 110:946-53. (Pubitemid 47267433)
57. Heib V, Becker M, Taube C et al. Advances in the understanding of mast cell function. Br J Haematol 2008; 142:683-94.
58. McLachlan JB, Shelburne CP, Hart JP et al. Mast cell activators: a new class of highly effective vaccine adjuvants. Nat Med 2008; 14:536-41. (Pubitemid 351655217)
59. Hofmann AM, Abraham SN. New roles for mast cells in modulating allergic reactions and immunity against pathogens. Curr Opin Immunol 2009; 21:679-86.
60. Kunder CA, St John AL, Li G et al. Mast cell-derived particles deliver peripheral signals to remote lymph nodes. J Exp Med 2009; 206:2455-67.
61. McKee AS, Munks MW, MacLeod MK et al. Alum induces innate immune responses through macrophage and mast cell sensors, but these sensors are not required for alum to act as an adjuvant for specific immunity. J Immunol 2009; 183:4403-14.
62. Shelburne CP, Nakano H, St John AL et al. Mast cells augment adaptive immunity by orchestrating dendritic cell trafficking through infected tissues. Cell Host Microbe 2009; 6:331-42.
63. Kulka M, Alexopoulou L, Flavell RA et al. Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3. J Allergy Clin Immunol 2004; 114:174-82. (Pubitemid 39005135)
64. Marshall JS, Jawdat DM. Mast cells in innate immunity. J Allergy Clin Immunol 2004; 114:21-7. (Pubitemid 39005114)
65. Marshall JS, Brown MG, Pawankar R. in Allergy Frontiers, Vol 2: Classification and Pathomechanisms (ed. Pawankar R, Holgate ST, Rosenwasser LJ) 113-133 (Springer Japan, 2009).
66. Supajatura V, Ushio H, Nakao A et al. Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity. J Clin Invest 2002; 109:1351-9. (Pubitemid 34546900)
67. Orinska Z, Bulanova E, Budagian V et al. TLR3-induced activation of mast cells modulates CD8+T-cell recruitment. Blood 2005; 106:978-87. (Pubitemid 41076443)
68. Wu L, Feng BS, He SH et al. Bacterial peptidoglycan breaks down intestinal tolerance via mast cell activation: the role of TLR2 and N0D2. Immunol Cell Biol 2007; 85:538-45. (Pubitemid 47530587)
69. Feng BS, He SH, Zheng PY et al. Mast cells play a crucial role in Staphylococcus aureus peptidoglycan-induced diarrhea. Am J Pathol 2007; 171:537-47.
70. Okumura S, Yuki K, Kobayashi R et al. Hyperexpression of N0D2 in intestinal mast cells of Crohn's disease patients: preferential expression of inflammatory cell-recruiting molecules via NOD2 in mast cells. Clin Immunol 2009; 130:175-85.
71. Nakamura Y, Kambe N, Saito M et al. Mast cells mediate neutrophil recruitment and vascular leakage through the NLRP3 inflammasome in histamine-independent urticaria. J Exp Med 2009; 206:1037-46.
72. Martinon F, Mayor A, Tschopp J. The inflammasomes: guardians of the body. Annu Rev Immunol 2009; 27:229-65.
73. Stutz A, Golenbock DT, Latz E. Inflammasomes: too big to miss. J Clin Invest 2009; 119:3502-11.
74. Iwasaki A, Medzhitov R. Regulation of adaptive immunity by the innate immune system. Science 2010; 327:291-5.
75. Gutzmer R, Diestel C, Mommert S et al. Histamine H4 receptor stimulation suppresses IL- 12p70 production and mediates chemotaxis in human monocyte-derived dendritic cells. J Immunol 2005; 174:5224-32. (Pubitemid 40593160)
76. Mazzoni A, Young HA, Spitzer JH et al. Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T-cell polarization. J Clin Invest 2001; 108:1865-73. (Pubitemid 34015132)
77. Caron G, Delneste Y, Roelandts E et al. Histamine polarizes human dendritic cells into Th2 cell-promoting effector dendritic cells. J Immunol 2001; 167:3682-6. (Pubitemid 32910811)
78. Mazzoni A, Leifer CA, Mullen GE et al. Cutting edge: histamine inhibits IFN-alpha release from plasmacytoid dendritic cells. J Immunol 2003; 170:2269-73. (Pubitemid 36245610)
79. Kitawaki T, Kadowaki N, Sugimoto N et al. IgE-activated mast cells in combination with pro-inflammatory factors induce Th2-promoting dendritic cells. Int Immunol 2006; 18:1789-99. (Pubitemid 44884041)
80. Theiner G, Gessner A, Lutz MB. The mast cell mediator PGD2 suppresses IL-12 release by dendritic cells leading to Th2 polarized immune responses in vivo. Immunobiology 2006; 211:463-72.
81. Kalinski P, Hilkens CM, Snijders A et al. IL-12-deficient dendritic cells, generated in the presence of prostaglandin E 2, promote type 2 cytokine production in maturing human naive T helper cells. J. Immunol, 1997; 159, 28-35. (Pubitemid 127493681)
82. Mazzoni A, Siraganian RP, Leifer CA et al. Dendritic cell modulation by mast cells controls the Th1/Th2 balance in responding T-cells. J Immunol 2006; 177:3577-81. (Pubitemid 44359888)
83. Gosset P, Bureau F, Angeli V et al. Prostaglandin D2 affects the maturation of human monocyte-derived dendritic cells: consequence on the polarization of naive Th cells. J Immunol 2003; 170:4943-52. (Pubitemid 36554723)
84. Gosset P, Pichavant M, Faveeuw C et al. Prostaglandin D2 affects the differentiation and functions ofhuman dendritic cells: impact on the T-cell response. Eur J Immunol 2005; 35:1491-500. (Pubitemid 40691431)
85. Del Prete A, Shao WH, Mitola S et al. Regulation of dendritic cell migration and adaptive immune response by leukotriene B4 receptors: a role for LTB4 in up-regulation of CCR7 expression and function. Blood 2007; 109:626-31. (Pubitemid 46105963)
86. Skokos D, Botros HG, Demeure C et al. Mast cell-derived exosomes induce phenotypic and functional maturation of dendritic cells and elicit specific immune responses in vivo. J Immunol 2003; 170:3037-45. (Pubitemid 36302178)
87. Bryce PJ et al. Immune sensitization in the skin is enhanced by antigen-independent effects of IgE. Immunity 2004; 20:381-92. (Pubitemid 38482117)
88. Jawdat DM, Albert EJ, Rowden G et al. IgE-mediated mast cell activation induces Langerhans cell migration in vivo. J Immunol 2004; 173:5275-82. (Pubitemid 39387811)
89. Suto H, Nakae S, Kakurai M et al. Mast cell-associated TNF promotes dendritic cell migration. J Immunol 2006; 176:4102-12. (Pubitemid 44264389)
90. Jawdat DM, Rowden G, Marshall JS. Mast cells have a pivotal role in TNF-independent lymph node hypertrophy and the mobilization of Langerhans cells in response to bacterial peptidoglycan. J Immunol 2006; 177:1755-62. (Pubitemid 44092512)
91. Dawicki W, Jawdat DW, Xu N et al. Mast cells, histamine and IL-6 regulate the selective influx of dendritic cell subsets into an inflamed lymph node. J Immunol 2010: 184:2116-23.
92. Mekori YA, Metcalfe DD. Mast cell-T-cell interactions. J Allergy Clin Immunol 1999; 104:517-23.
93. Nakae S, Suto H, Kakurai M et al. Mast cells enhance T-cell activation: importance of mast cell-derived TNF. Proc Natl Acad Sci USA 2005; 102:6467-72. (Pubitemid 40617466)
94. Krishnaswamy G, Lakshman T, Miller AR et al. Multifunctional cytokine expression by human mast cells: regulation by T-cell membrane contact and glucocorticoids. J Interferon Cytokine Res 1997; 17:167-76. (Pubitemid 27148707)
95. Bhattacharyya SP, Drucker I, Reshef T et al. Activated T-lymphocytes induce degranulation and cytokine production by human mast cells following cell-to-cell contact. J Leukoc Biol 1998; 63:337-41. (Pubitemid 28106847)
96. Inamura N, Mekori YA, Bhattacharyya SP et al. Induction and enhancement of Fc(epsilon)RI-dependent mast cell degranulation following coculture with activated T-cells: dependency on ICAM-1 - and leukocyte function-associated antigen (LFA)-1-mediated heterotypic aggregation. J Immunol 1998; 160:4026-33. (Pubitemid 28176112)
97. Baram D, Vaday GG, Salamon P et al. Human mast cells release metalloproteinase-9 on contact with activated T-cells: juxtacrine regulation by TNF-alpha. J Immunol 2001; 167:4008-16.
98. Stopfer P, Mannel DN, Hehlgans T. Lymphotoxin-beta receptor activation by activated T-cells induces cytokine release from mouse bone marrow-derived mast cells. J Immunol 2004; 172:7459-65. (Pubitemid 38747608)
99. Henz BM, Maurer M, Lippert U et al. Mast cells as initiators of immunity and host defense. Exp Dermatol 2001; 10:1-10. (Pubitemid 32101358)
100. Fox CC, Jewell SD, Whitacre CC. Rat peritoneal mast cells present antigen to a PPD-specific T-cell line. Cell Immunol 1994; 158:253-64. (Pubitemid 24321648)
101. Poncet P, Arock M, David B. MHC class II-dependent activation of CD4+ T-cell hybridomas by human mast cells through superantigen presentation. J Leukoc Biol 1999; 66:105-12. (Pubitemid 29321377)
102. Malaviya R, Twesten NJ, Ross EA et al. Mast cells process bacterial Ags through a phagocytic route for class I MHC presentation to T-cells. J Immunol 1996; 156:1490-6. (Pubitemid 26065860)
103. Stelekati E, Bahri R, D'Orlando O et al. Mast cell-mediated antigen presentation regulates CD8*T-cell effector functions. Immunity 2009; 31:665-76.
104. Gaudenzio N, Espagnolle N, Mars LT et al. Cell-cell cooperation at the Thelper cell/mast cell immunological synapse. Blood 2009; 114:4979-88.
105. Kambayashi T, Allenspach EJ, Chang JT et al. Inducible MHC class II expression by mast cells supports effector and regulatory T-cell activation. J Immunol 2009; 182:4686-95.
106. Frandji P, Tkaczyk C, Oskeritzian C et al. Presentation of soluble antigens by mast cells: upregulation by interleukin-4 and granulocyte/macrophage colony-stimulating factor and downregulation by interferon-gamma. Cell Immunol 1995; 163:37-46.
107. Frandji P, Tkaczyk C, Oskeritzian C et al. Exogenous and endogenous antigens are differentially presented by mast cells to CD4+ T-lymphocytes. Eur J Immunol 1996; 26:2517-28. (Pubitemid 26340958)
108. Nakano N, Nishiyama C, Yagita H et al. Notch signaling confers antigen-presenting cell functions on mast cells. J Allergy Clin Immunol 2009; 123:74-81 e1.
109. Lu LF, Lind EF, Gondek DC et al. Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 2006; 442:997-1002. (Pubitemid 44330250)
110. Skokos D, Le Panse S, Villa I et al. Mast cell-dependent B and T-lymphocyte activation is mediated by the secretion of immunologically active exosomes. J. Immunol. 2001; 166:868-76. (Pubitemid 32060240)
111. Kambayashi T, Baranski JD, Baker RG et al. Indirect involvement of allergen-captured mast cells in antigen presentation. Blood 2008; 111:1489-96. (Pubitemid 351213437)
112. Tkaczyk C, Viguier M, Boutin Y et al. Specific antigen targeting to surface IgE and IgG on mouse bone marrow-derived mast cells enhances efficiency of antigen presentation. Immunology 1998: 94:318-24. (Pubitemid 28318595)
113. Tkaczyk C, Villa I, Peronet R et al. FcepsilonRI-mediated antigen endocytosis turns interferon-gamma-treated mouse mast cells from inefficient into potent antigen-presenting cells. Immunology 1999: 97:333-40. (Pubitemid 29274168)
114. Kashiwakura J, Yokoi H, Saito H et al. T-cell proliferation by direct cross-talk between OX40 ligand on human mast cells and 0X40 on human T-cells: comparison of gene expression profiles between human tonsillar and lung-cultured mast cells. J. Immunol. 2004; 173:5247-57. (Pubitemid 39387808)
115. Nakae S, Suto H, Iikura M et al. Mast cells enhance T-cell activation: importance ofmast cell costimulatory molecules and secreted TNF. J Immunol 2006; 176:2238-48. (Pubitemid 43201671)
116. Suto H, Nakae S, Kakurai M et al. Mast cell-associated TNF promotes dendritic cell migration. J Immunol 2006; 176:4102-12. (Pubitemid 44264389)
117. Jawdat DM, Rowden G, Marshall JS. Mast cells have a pivotal role in TNF-independent lymph node hypertrophy and the mobilization of Langerhans cells in response to bacterial peptidoglycan. J Immunol 2006; 177:1755-62. (Pubitemid 44092512)
118. Dawicki W, Jawdat DW, Xu N et al. Mast cells, histamine and IL-6 regulate the selective influx of dendritic cell subsets into an inflamed lymph node. J Immunol 2010: 184:2116-23.
119. Mekori YA, Metcalfe DD. Mast cell-T-cell interactions. J Allergy Clin Immunol 1999; 104:517-23.
120. Nakae S, Suto H, Kakurai M et al. Mast cells enhance T-cell activation: importance of mast cell-derived TNF. Proc Natl Acad Sci USA 2005; 102:6467-72. (Pubitemid 40617466)
121. Krishnaswamy G, Lakshman T, Miller AR et al. Multifunctional cytokine expression by human mast cells: regulation by T-cell membrane contact and glucocorticoids. J Interferon Cytokine Res 1997; 17:167-76. (Pubitemid 27148707)
122. Bhattacharyya SP, Drucker I, Reshef T et al. Activated T-lymphocytes induce degranulation and cytokine production by human mast cells following cell-to-cell contact. J Leukoc Biol 1998; 63:337-41. (Pubitemid 28106847)
123. Inamura N, Mekori YA, Bhattacharyya SP et al. Induction and enhancement of Fc(epsilon)RI-dependent mast cell degranulation following coculture with activated T-cells: dependency on ICAM-1 - and leukocyte function-associated antigen (LFA)-1-mediated heterotypic aggregation. J Immunol 1998; 160:4026-33. (Pubitemid 28176112)
124. Baram D, Vaday GG, Salamon P et al. Human mast cells release metalloproteinase-9 on contact with activated T-cells: juxtacrine regulation by TNF-alpha. J Immunol 2001; 167:4008-16. (Pubitemid 32910846)
125. Stopfer P, Mannel DN, Hehlgans T. Lymphotoxin-beta receptor activation by activated T-cells induces cytokine release from mouse bone marrow-derived mast cells. J Immunol 2004; 172:7459-65. (Pubitemid 38747608)
126. Henz BM, Maurer M, Lippert U et al. Mast cells as initiators of immunity and host defense. Exp Dermatol 2001; 10:1-10. (Pubitemid 32101358)
127. Fox CC, Jewell SD, Whitacre CC. Rat peritoneal mast cells present antigen to a PPD-specific T-cell line. Cell Immunol 1994; 158:253-64. (Pubitemid 24321648)
128. Poncet P, Arock M, David B. MHC class II-dependent activation of CD4+ T-cell hybridomas by human mast cells through superantigen presentation. J Leukoc Biol 1999; 66:105-12. (Pubitemid 29321377)
129. Malaviya R, Twesten NJ, Ross EA et al. Mast cells process bacterial Ags through a phagocytic route for class I MHC presentation to T-cells. J Immunol 1996; 156:1490-6. (Pubitemid 26065860)
130. Stelekati E, Bahri R, D'Orlando O et al. Mast cell-mediated antigen presentation regulates CD8*T-cell effector functions. Immunity 2009; 31:665-76.
131. Gaudenzio N, Espagnolle N, Mars LT et al. Cell-cell cooperation at the Thelper cell/mast cell immunological synapse. Blood 2009; 114:4979-88.
132. Kambayashi T, Allenspach EJ, Chang JT et al. Inducible MHC class II expression by mast cells supports effector and regulatory T-cell activation. J Immunol 2009; 182:4686-95.
133. Frandji P, Tkaczyk C, Oskeritzian C et al. Presentation of soluble antigens by mast cells: upregulation by interleukin-4 and granulocyte/macrophage colony-stimulating factor and downregulation by interferon-gamma. Cell Immunol 1995; 163:37-46.
134. Frandji P, Tkaczyk C, Oskeritzian C et al. Exogenous and endogenous antigens are differentially presented by mast cells to CD4+ T-lymphocytes. Eur J Immunol 1996; 26:2517-28. (Pubitemid 26340958)
135. Nakano N, Nishiyama C, Yagita H et al. Notch signaling confers antigen-presenting cell functions on mast cells. J Allergy Clin Immunol 2009; 123:74-81 e1.
136. Lu LF, Lind EF, Gondek DC et al. Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 2006; 442:997-1002. (Pubitemid 44330250)
137. Skokos D, Le Panse S, Villa I et al. Mast cell-dependent B and T-lymphocyte activation is mediated by the secretion of immunologically active exosomes. J. Immunol. 2001; 166:868-76. (Pubitemid 32060240)
138. Kambayashi T, Baranski JD, Baker RG et al. Indirect involvement of allergen-captured mast cells in antigen presentation. Blood 2008; 111:1489-96. (Pubitemid 351213437)
139. Tkaczyk C, Viguier M, Boutin Y et al. Specific antigen targeting to surface IgE and IgG on mouse bone marrow-derived mast cells enhances efficiency of antigen presentation. Immunology 1998: 94:318-24. (Pubitemid 28318595)
140. Tkaczyk C, Villa I, Peronet R et al. FcepsilonRI-mediated antigen endocytosis turns interferon-gamma-treated mouse mast cells from inefficient into potent antigen-presenting cells. Immunology 1999: 97:333-40. (Pubitemid 29274168)
141. Kashiwakura J, Yokoi H, Saito H et al. T-cell proliferation by direct cross-talk between OX40 ligand on human mast cells and 0X40 on human T-cells: comparison of gene expression profiles between human tonsillar and lung-cultured mast cells. J. Immunol. 2004; 173:5247-57. (Pubitemid 39387808)
142. Nakae S, Suto H, Iikura M et al. Mast cells enhance T-cell activation: importance ofmast cell costimulatory molecules and secreted TNF. J Immunol 2006; 176:2238-48. (Pubitemid 43201671)
143. Bischoff SC. Role of mast cells in allergic and non-allergic immune responses: comparison of human and murine data. Nat Rev Immunol 2007; 7:93-104. (Pubitemid 46174857)
144. Takenaka H, Ushio H, Niyonsaba F et al. Synergistic augmentation of inflammatory cytokine productions from murine mast cells by monomeric IgE and toll-like receptor ligands. Biochem Biophys Res Commun 2010; 391:471-6.
145. Qiao H, Andrade MV, Lisboa FA et al. FcepsilonR1 and toll-like receptors mediate synergistic signals to markedly augment production of inflammatory cytokines in murine mast cells. Blood 2006: 107:610-8. (Pubitemid 43076385)
146. Hart PH, Townley SL, Grimbaldeston MA et al. Mast cells, neuropeptides, histamine and prostaglandins in UV-induced systemic immunosuppression. Methods 2002; 28:79-89.
147. Metz M, Lammel V, Gibbs BF et al. Inflammatory murine skin responses to UV-B light are partially dependent on endothelin-1 and mast cells. Am J Pathol 2006; 169:815-22. (Pubitemid 44411949)
148. Biggs L et al. Evidence that vitamin D3 promotes mast cell-dependent reduction of chronic UVB-induced skin pathology in mice. J Exp Med 2010; 207:455-63.
149. Alard P, Niizeki H, Hanninen L et al. Local ultraviolet B irradiation impairs contact hypersensitivity induction by triggering release of tumor necrosis factor-alpha from mast cells. Involvement of mast cells and Langerhans cells in susceptibility to ultraviolet B. J Invest Dermatol 1999; 113:983-90. (Pubitemid 30013342)
150. Secor VH, Secor WE, Gutekunst CA et al. Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J Exp Med 2000; 191:813-22.
151. Robbie-Ryan M, Tanzola MB, Secor VH et al. Cutting edge: both activating and inhibitory Fc receptors expressed on mast cells regulate experimental allergic encephalomyelitis disease severity. J Immunol 2003; 170:1630-4. (Pubitemid 36197375)
152. Gregory GD, Raju SS, Winandy S et al. Mast cell IL-4 expression is regulated by Ikaros and influences encephalitogenic Th1 responses in EAE. J Clin Invest 2006; 116:1327-36.
153. Sayed BA, Christy AL, Walker ME et al. Meningeal mast cells affect early T-cell central nervous system infiltration and blood-brain barrier integrity through TNF: a role for neutrophil recruitment? J Immunol 2010; 184:6891-900.
154. Williams CM, Galli SJ. The diverse potential effector and immunoregulatory roles of mast cells in allergic disease. J Allergy Clin Immunol 2000; 105:847-59. (Pubitemid 30324391)
155. Yu M, Tsai M, Tam SY et al. Mast cells can promote the development of multiple features of chronic asthma in mice. J Clin Invest 2006; 116:1633-41.
156. Williams CM, Galli SJ. Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice. J Exp Med 2000; 192:455-62. (Pubitemid 30629171)
157. Taube C, Wei X, Swasey CH et al. Mast cells, FcepsilonRI and IL-13 are required for development of airway hyperresponsiveness after aerosolized allergen exposure in the absence of adjuvant. J Immunol 2004; 172:6398-406. (Pubitemid 38621249)
158. Nakae S, Ho LH, Yu M et al. Mast cell-derived TNF contributes to airway hyperreactivity, inflammation and TH2 cytokine production in an asthma model in mice. J Allergy Clin Immunol 2007; 120:48-55. (Pubitemid 46990488)
159. Kim YS, Ko HM, Kang NI et al. Mast cells play a key role in the development of late airway hyperresponsiveness through TNF-alpha in a murine model of asthma. Eur J Immunol 2007; 37:1107-15.
160. Reuter S, Heinz A, Sieren M et al. Mast cell-derived tumour necrosis factor is essential for allergic airway disease. Eur Respir J 2008; 31:773-82.
161. Goodarzi K, Goodarzi M, Tager AM et al. Leukotriene B4 and BLT1 control cytotoxic effector T-cell recruitment to inflamed tissues. Nat Immunol 2003: 4:965-73. (Pubitemid 37265917)
162. Tager AM, Bromley SK, Medoff BD et al. Leukotriene B4 receptor BLT1 mediates early effector T-cell recruitment. Nat Immunol 2003; 4:982-90. (Pubitemid 37265919)
163. Ott VL, Cambier JC, Kappler J et al. Mast cell-dependent migration of effector CD8*T-cells through production of leukotriene B4. Nat Immunol 2003; 4:974-81. (Pubitemid 37265918)
164. Nakae S, Suto H, Berry GJ et al. Mast cell-derived TNF can promote Th17 cell-dependent neutrophil recruitment in ovalbumin-challenged OTII mice. Blood 2007; 109:3640-8. (Pubitemid 46641710)
165. Waern I, Jonasson S, Hjoberg J et al. Mouse mast cell protease 4 is the major chymase in murine airways and has a protective role in allergic airway inflammation. J Immunol 2009: 183:6369-76.
166. Kakurai M, Monteforte R, Suto H et al. Mast cell-derived tumor necrosis factor can promote nerve fiber elongation in the skin during contact hypersensitivity in mice. Am J Pathol 2006; 169:1713-21. (Pubitemid 351182002)
167. Norman MU, Hwang J, Hulliger S et al. Mast cells regulate the magnitude and the cytokine microenvironment of the contact hypersensitivity response. Am J Pathol 2008; 172:1638-49. (Pubitemid 351793355)
168. Lee DM, Friend DS, Gurish MF et al. Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science 2002; 297:1689-92. (Pubitemid 35000781)
169. Nigrovic PA, Binstadt BA, Monach PA et al. Mast cells contribute to initiation of autoantibody-mediated arthritis via IL-1. Proc Natl Acad Sci USA 2007; 104:2325-30. (Pubitemid 46391396)
170. Chen R, Ning G, Zhao ML et al. Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid. J Clin Invest 2001; 108:1151-8. (Pubitemid 32995373)
171. Scandiuzzi L, Beghdadi W, Daugas E et al. Mouse mast cell protease-4 deteriorates renal function by contributing to inflammation and fibrosis in immune complex-mediated glomerulonephritis. J Immunol 2010; 185:624-33.
172. Depinay N, Hacini F, Beghdadi W et al. Mast cell-dependent down-regulation of antigen-specific immune responses by mosquito bites. J Immunol 2006; 176:4141-6. (Pubitemid 44264393)
173. Limon-Flores AY, Chacon-Salinas R, Ramos G et al. Mast cells mediate the immune suppression induced by dermal exposure to JP-8 jet fuel. Toxicol Sci 2009; 112:144-52.
174. Beissert S, Schwarz A, Schwarz T. Regulatory T-cells. J Invest Dermatol 2006; 126:15-24.
175. O'Garra A, Vieira P. TH1 cells control themselves by producing interleukin-10. Nat Rev Immunol 2007; 7:425-8. (Pubitemid 46834852)
176. Frossi B, Gri G, Tripodo C et al. Exploring a regulatory role for mast cells: 'MCregs'? Trends Immunol 2010; 31:97-102.
177. Hershko AY, Rivera J. Mast cell and T-cell communication: amplification and control of adaptive immunity. Immunol Lett 2010; 128:98-104.
178. Boerma M, Fiser WP, Hoyt G et al. Influence of mast cells on outcome after heterotopic cardiac transplantation in rats. Transpl Int 2007; 20:256-65.
179. Itoh S, Nakae S, Velotta JB et al. The role of recipient mast cells in acute and chronic cardiac allograft rejection in C57BL/6-KitW-sh/W-sh mice. J Heart Lung Transplant 2010; 29:401-9.
180. de Vries VC, Wasiuk A, Bennett KA et al. Mast cell degranulation breaks peripheral tolerance. Am J Transplant 2009; 9:2270-80.
181. Piconese S, Gri G, Tripodo C et al. Mast cells counteract regulatory T-cell suppression through interleukin-6 and OX40/OX40L axis toward Th17-cell differentiation. Blood 2009; 114:2639-48.
182. Gri G, Piconese S, Frossi B et al. CD4+CD25+regulatory T-cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction. Immunity 2008; 29:771-81.
183. Askenase PW, Van Loveren H, Kraeuter-Kops S et al. Defective elicitation ofdelayed-type hypersensitivity in W/Wv and Sl/Sld mast cell-deficient mice. J Immunol 1983: 131:2687-94. (Pubitemid 14208815)
184. Biedermann T, Kneilling M, Mailhammer R et al. Mast cells control neutrophil recruitment during T-cell-mediated delayed-type hypersensitivity reactions through tumor necrosis factor and macrophage inflammatory protein 2. J Exp Med 2000: 192:1441-52.